CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. “We are excited to have Matt join the Company... Read more
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA... Read more
3D printing offers great flexibility in the creation of precisely engineered objects with highly complex geometries. This is rapidly opening up possibilities in many fields, including aerospace, robotics, construction and medicine. External content Nature Communications: 3D printing of inherently nanoporous polymers via polymerization-induced phase separation 3D printing offers enormous flexibility in fabrication of polymer objects... Read more
Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions Three new testing kits are among the first to specify the mutations of the recently discovered Omicron variant, and can help manage the evolving COVID-19 pandemic Use of... Read more
Includes robust dual-target SARS-CoV-2 detection and identification of 4 S-gene mutations Reliable detection and even tentative differentiation of Omicron variant expected Validated with the GenoXtract® and GenoXtract ® fleXT extraction system Validated with Bruker’s novel FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its established CE-IVD marked FluoroType®... Read more
Effective at the open of market trading today, the Company will begin trading as Azenta, Inc. (Nasdaq: AZTA) CHELMSFORD, Mass., Dec. 1, 2021 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or the “Company”) announced today that it has completed its previously announced corporate name change from “Brooks Automation, Inc.” to “Azenta, Inc.” In conjunction with the corporate name... Read more
Diagnostic accuracy of PerkinElmer’s COVID-19 PCR tests remains unaffected WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 29, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the performance of its SARS-CoV-2 RT-PCR assays are not impacted by the emergence of Omicron (B.1.1.529), a variant of concern that was recently identified... Read more
The PKeye Workflow Monitor offers 24/7 monitoring capabilities to ensure high productivity and throughput WALTHAM, Mass. – November 22, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer... Read more
Brooks Automation Announces Planned Name and Stock Ticker Symbol Change – Azenta, Inc. (Nasdaq: AZTA) Set to Begin Trading Effective December 1st CHELMSFORD, Mass., Nov. 16, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced at its investor day earlier today that it is changing its name to Azenta, Inc. and will begin trading on Nasdaq... Read more
MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the launch of the HiFiViral SARS-CoV-2 Kit – a fully kitted end-to-end solution for COVID-19 surveillance, which public health laboratories can use to identify new SARS-CoV-2 variants and detect all variants circulating... Read more